Literature DB >> 21254967

Proteinase, phospholipase, biofilm forming abilities and antifungal susceptibilities of Malaysian Candida isolates from blood cultures.

Sun Tee Tay1, Ira Azzura Zainal Abidin, Hamimah Hassan, Kee Peng Ng.   

Abstract

This study was conducted to determine the proteinase, phospholipase, and biofilm forming abilities of Candida isolates in blood cultures of specimens from patients at the University Malaya Medical Center, Kuala Lumpur, Malaysia. Proteinase and phospholipase activities were detected in 93.7% and 73.3%, respectively, of 15 Candida albicans isolates. Amongst the 26 non-C. albicans Candida isolates, proteinase and phospholipase activities were detected in 88.5% and 7.7% of the isolates, respectively. There was no significant difference in the expression levels of proteinase amongst the Candida isolates studied (P = 0.272), but the phospholipase activity of C. albicans was significantly higher than that of the non-C. albicans Candida isolates (P = 0.003). There was no significant difference in the biofilm forming abilities of C. albicans and non-C. albicans Candida isolates on the polystyrene microtiter wells (P = 0.379). In addition, the findings of this study demonstrate increased resistance of Candida isolates in biofilms to amphotericin and fluconazole, as compared to their planktonic counterparts.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21254967     DOI: 10.3109/13693786.2010.551424

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  8 in total

1.  Occurrence and characterization of Candida nivariensis from a culture collection of Candida glabrata clinical isolates in Malaysia.

Authors:  Sun Tee Tay; Azadeh Lotfalikhani; Negar Shafiei Sabet; Sasheela Ponnampalavanar; Sofiah Sulaiman; Shiang Ling Na; Kee Peng Ng
Journal:  Mycopathologia       Date:  2014-07-15       Impact factor: 2.574

2.  Species Distribution, Virulence Factors, and Antifungal Susceptibility Among Candida parapsilosis Complex Isolates Recovered from Clinical Specimens.

Authors:  Beatriz Virgínia da Silva; Larissa Beatriz Silva; Diego Batista Carneiro de Oliveira; Paulo Roberto da Silva; Kennio Ferreira-Paim; Leonardo Euripides Andrade-Silva; Mario León Silva-Vergara; Anderson Assunção Andrade
Journal:  Mycopathologia       Date:  2015-07-03       Impact factor: 2.574

3.  Growth inhibition of Candida species by Wickerhamomyces anomalus mycocin and a lactone compound of Aureobasidium pullulans.

Authors:  Sun-Tee Tay; Su-Lin Lim; Hui-Wee Tan
Journal:  BMC Complement Altern Med       Date:  2014-11-08       Impact factor: 3.659

4.  Extracellular enzymes and susceptibility to fluconazole in Candida strains isolated from patients with vaginitis and healthy individuals.

Authors:  Zahra Seifi; Ali Zarei Mahmoudabadi; Majid Zarrin
Journal:  Jundishapur J Microbiol       Date:  2015-03-21       Impact factor: 0.747

5.  Prevalence, virulence and antifungal activity of C. albicans isolated from infected root canals.

Authors:  Sheela B Abraham; Farah Al Marzooq; Wan Harun Himratul-Aznita; Hany Mohamed Aly Ahmed; Lakshman Perera Samaranayake
Journal:  BMC Oral Health       Date:  2020-12-01       Impact factor: 2.757

6.  Candida albicans  Genotyping and Relationship of Virulence Factors with Fluconazole Tolerance in Infected Pediatric Patients.

Authors:  Ghada El-Saeed Mashaly; Mayada Sabry Zeid
Journal:  Infect Drug Resist       Date:  2022-04-21       Impact factor: 4.177

7.  Triclosan Demonstrates Synergic Effect with Amphotericin B and Fluconazole and Induces Apoptosis-Like Cell Death in Cryptococcus neoformans.

Authors:  Elaheh Movahed; Grace Min Yi Tan; Komathy Munusamy; Tee Cian Yeow; Sun Tee Tay; Won Fen Wong; Chung Yeng Looi
Journal:  Front Microbiol       Date:  2016-03-21       Impact factor: 5.640

8.  Antifungal Susceptibility in Serum and Virulence Determinants of Candida Bloodstream Isolates from Hong Kong.

Authors:  Chaminda J Seneviratne; Suhasini Rajan; Sarah S W Wong; Dominic N C Tsang; Christopher K C Lai; Lakshman P Samaranayake; Lijian Jin
Journal:  Front Microbiol       Date:  2016-02-26       Impact factor: 5.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.